The different focus of both companies is also reflected in Chr. Hansen bidding
data, which show they rarely compete with one another on sales projects. Out of the [number] global sales projects Chr. Hansen has worked on between 2020 and 2023, Novozymes is only mentioned as a key competitor in [percentage] of projects.217